The PE Ratio as of September 2024 (TTM) for Aptinyx Inc. (APTX) is -0.06

According to Aptinyx Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.06. This represents a change of -71.49% compared to the average of -0.21 of the last 4 quarters.

Aptinyx Inc. (APTX) Historical PE Ratio (quarterly & annually)

How has APTX PE Ratio performed in the past?

The mean historical PE Ratio of Aptinyx Inc. over the last ten years is -9.16. The current -0.06 PE Ratio has changed -34.48% with respect to the historical average. Over the past ten years (40 quarters), APTX's PE Ratio was at its highest in in the December 2022 quarter at 0.19. The PE Ratio was at its lowest in in the December 2017 quarter at -17.95.

Aptinyx Inc. (APTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aptinyx Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptinyx Inc. (APTX) Average PE Ratio

How has APTX PE Ratio performed in the past?

The current PE Ratio of Aptinyx Inc. (APTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aptinyx Inc. (APTX) PE Ratio vs. Peers

How is APTX’s PE Ratio compared to its peers?

Aptinyx Inc.’s PE Ratio is less than Evelo Biosciences, Inc. (-0.00), less than Magenta Therapeutics, Inc. (-0.04), greater than Aileron Therapeutics, Inc. (-2.25), greater than ABVC BioPharma, Inc. (-0.68), greater than Neoleukin Therapeutics, Inc. (-0.98), less than CytomX Therapeutics, Inc. (9.46), greater than Assembly Biosciences, Inc. (-2.21), greater than Instil Bio, Inc. (-3.43), greater than Nuvation Bio Inc. (-1.48), greater than Allarity Therapeutics, Inc. (-3.97), greater than NeuroBo Pharmaceuticals, Inc. (-0.75), less than Hillstream BioPharma, Inc. (-0.00), greater than Virax Biolabs Group Limited (-1.09), greater than Quoin Pharmaceuticals, Ltd. (-0.38), less than Spero Therapeutics, Inc. (4.17), greater than Achilles Therapeutics plc (-0.44), greater than Adial Pharmaceuticals, Inc. (-0.38), greater than TransCode Therapeutics, Inc. (-0.10), less than Aditxt, Inc. (-0.02), greater than Reviva Pharmaceuticals Holdings, Inc. (-0.94), greater than Avenue Therapeutics, Inc. (-0.29),

Build a custom stock screener for Aptinyx Inc. (APTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptinyx Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptinyx Inc. (APTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptinyx Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.